Alain Nguyen

Summary

Publications

  1. ncbi A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study)
    Alain Nguyen
    University Clinic of Infectious Diseases, University Hospital of Geneva, Switzerland
    AIDS 25:1481-7. 2011
  2. ncbi A randomized crossover study to compare efavirenz and etravirine treatment
    Alain Nguyen
    University Clinic of Infectious Diseases, University Hospital of Geneva, Switzerland
    AIDS 25:57-63. 2011
  3. ncbi HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial
    Alexandra Calmy
    HIV Unit, Geneva University Hospital, 15 rue Micheli Du Crest, Geneva 1205, Switzerland
    AIDS 23:929-39. 2009
  4. ncbi Safety and efficacy of once-daily nevirapine dosing: a multicohort study
    Alexandra Calmy
    Division of Infectious Disease HIV unit, University Hospital Geneva, Geneva, Switzerland
    Antivir Ther 14:931-8. 2009

Detail Information

Publications4

  1. ncbi A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study)
    Alain Nguyen
    University Clinic of Infectious Diseases, University Hospital of Geneva, Switzerland
    AIDS 25:1481-7. 2011
    ..We investigated the effect of replacing EFV with raltegravir (RAL) on patient preference, daytime sleepiness, sleep quality, anxiety, and lipid levels...
  2. ncbi A randomized crossover study to compare efavirenz and etravirine treatment
    Alain Nguyen
    University Clinic of Infectious Diseases, University Hospital of Geneva, Switzerland
    AIDS 25:57-63. 2011
    ..Efavirenz (EFV) causes neuropsychiatric side-effects and an unfavourable blood lipid profile. We investigated the effect of replacing EFV with etravirine (ETR) on patient preference, sleep, anxiety and lipid levels...
  3. ncbi HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial
    Alexandra Calmy
    HIV Unit, Geneva University Hospital, 15 rue Micheli Du Crest, Geneva 1205, Switzerland
    AIDS 23:929-39. 2009
    ..We investigated whether HIV replication modified the levels of these proteins in a combination antiretroviral therapy (cART) interruption trial...
  4. ncbi Safety and efficacy of once-daily nevirapine dosing: a multicohort study
    Alexandra Calmy
    Division of Infectious Disease HIV unit, University Hospital Geneva, Geneva, Switzerland
    Antivir Ther 14:931-8. 2009
    ..Nevirapine (NVP) is often prescribed once daily in clinical practice in combination with a once daily nucleoside backbone. We investigated the relationship of NVP dosing with safety and efficacy...